Search Results
Oct 24, 2025, 12:18 ET 再鼎醫藥公布Zocilurtatug Pelitecan（前稱ZL-1310）最新一期臨床數據， 顯示其成為同類首創用於小細胞肺癌的靶向DLL3 ADC的潛力，並啟動全球三期注冊研究
3 Sabari JK, et al. Nat Rev Clin Oncol. 2017;14:549-561.
More news about: 再鼎醫藥
Oct 23, 2025, 09:00 ET Gold Holds Above $4,100; Miners Poised to Capture Explosive Profit Margins
approved by Lake Victoria Gold Ltd. Technical information relating to Lake Victoria Gold Ltd. has been reviewed and approved by David Scott, Pr. Sci. Nat., a Qualified Person as defined by National Instrument 43-101. Mr. Scott is a registered member of the South African Council for Natural Scientific Professions
More news about: USA News Group
Oct 21, 2025, 19:30 ET PADCEV™ (enfortumab vedotin-ejfv) Plus KEYTRUDA® (pembrolizumab) sBLA Granted FDA Priority Review for Treatment of Certain Patients with Muscle-Invasive Bladder Cancer
MIBC. 5 Funt SA, Rosenberg JE. Systemic, perioperative management of muscle-invasive bladder cancer and future horizons. Nat Rev Clin Oncol. 2017 Apr;14(4):221-234. doi: 10.1038/nrclinonc.2016.188. Epub 2016 Nov 22. PMID: 27874062; PMCID: PMC6054138.6 Esteban-Villarrubia
More news about: Astellas Pharma Inc.
Oct 20, 2025, 09:00 ET RedHill's Talicia® Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal
(SEER). 9 Malfertheiner, P., Camargo, M.C., El-Omar, E. et al. Helicobacter pylori infection. Nat Rev Dis Primers 9, 19 (2023). https://doi.org/10.1038/s41572-023-00431-8
More news about: RedHill Biopharma Ltd.
Oct 19, 2025, 10:49 ET iOncologi Secures Foundational U.S. Patent as Landmark Studies Link COVID19 mRNA Vaccines to Improved Survival with Cancer Immunotherapy
Engineering (Qdaisat, S., et al. Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreading. Nat. Biomed. Eng 9, 1437–1452 [2025]). The study, led by researchers at the University of Florida, revealed how non–tumor-antigen-specific
More news about: iOncologi, Inc.
Oct 15, 2025, 11:56 ET iboss Launches MSSP SASE Platform -- Making Enterprise Cloud Security Accessible to Every MSSP and IT Reseller
buy, difficult to maintain, and slow to deploy. Most small businesses already use ISP-provided modems that include basic firewall functions such as NAT and DHCP. The iboss MSSP SASE Platform enables partners to completely eliminate new firewall purchases, moving all advanced security and connectivity
More news about: iboss
Oct 15, 2025, 09:00 ET UNPACK '26: HOTELS.COM AFSLØRER, HVORDAN REJSENDE VIL UDFORSKE VERDEN I 2026
bruge. Med Hotels.com Rewards sparer medlemmer 10 % eller mere på hundredtusindvis af hoteller over hele verden og tjener en bonusnat for hver tiende nat, de overnatter – ingen undtagelsesdatoer, ingen skjulte gebyrer. Vi gør også bookingen enkel og fleksibel med prisadvarsler og gratis afbestilling på
More news about: Expedia
Oct 14, 2025, 03:30 ET First patient treated with Leqembi® (lecanemab) in the Nordics
[4] Amin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12:3451. doi:10.1038/s41467-021-23507-z. [5] Ono K, Tsuji M. Protofibrils of Amyloid-β
More news about: BioArctic
Oct 13, 2025, 10:57 ET U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ® (upadacitinib) for the Treatment of Inflammatory Bowel Disease
and its management. Am J Manag Care. 2016 Mar;22(3 Suppl):s51-60. Kaplan, G. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):720-7. doi: 10.1038/nrgastro.2015.150. Gajendran M., et al. A comprehensive review
More news about: AbbVie
Oct 10, 2025, 07:30 ET Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress
Sanacora G, Zarate C, Krystal J, et al. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov. 2008;7(5):426-437. doi:10.1038/nrd2462 Recourt K, de Boer P, Zuiker R, et al. The selective orexin-2
More news about: Johnson & Johnson
Oct 09, 2025, 12:51 ET oneworld Innovation Summit showcases airlines and innovators powering the future of flight
are exploring, investing in and deploying innovation that is reshaping aviation, and they are collectively doing so at an industry-leading rate," said Nat Pieper, chief executive officer of oneworld. "We have a wealth of expertise across our alliance, uniquely positioning us to bring parties together
More news about: oneworld Management Company, Inc
Oct 09, 2025, 11:30 ET Gold Hits $4,000 As Miner Funds Post Best Year Since 1979
approved by Lake Victoria Gold Ltd. Technical information relating to Lake Victoria Gold Ltd. has been reviewed and approved by David Scott, Pr. Sci. Nat., a Qualified Person as defined by National Instrument 43-101. Mr. Scott is a registered member of the South African Council for Natural Scientific Professions
More news about: Equity Insider
Oct 07, 2025, 08:05 ET OCuSOFT Inc. Announces Agreement with NORWOOD Device & Diagnostics
NORWOOD/OCuSOFT® relationship: "By sheer serendipity, I met Rick on a plane ride to a trade show in Las Vegas. That chance meeting gave me and my co-founder, Nat Adkins, our Executive Chairman, the opportunity to get to know Rick and his business. While the business synergies were obvious, Rick's character and
More news about: OCuSOFT Inc.
Oct 06, 2025, 18:05 ET Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.
[4] Amin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12:3451. doi:10.1038/s41467-021-23507-z. [5] Ono K, Tsuji M. Protofibrils of Amyloid-β
More news about: BioArctic
Oct 06, 2025, 18:02 ET Leqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.
[4] Amin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12:3451. doi:10.1038/s41467-021-23507-z. [5] Ono K, Tsuji M. Protofibrils of Amyloid-β
More news about: BioArctic
Oct 06, 2025, 16:30 ET Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease
2021;26(10):5481-5503. Amin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12:3451. doi:10.1038/s41467-021-23507-z Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a
More news about: Eisai Inc.
Oct 06, 2025, 08:00 ET RedHill Biopharma Signs New $1.8 Million Plus Sales Royalties Middle East Deal For Talicia®
(SEER). 15 Malfertheiner, P., Camargo, M.C., El-Omar, E. et al. Helicobacter pylori infection. Nat Rev Dis Primers 9, 19 (2023). https://doi.org/10.1038/s41572-023-00431-8
More news about: RedHill Biopharma Ltd.
Oct 02, 2025, 20:02 ET ERS 2025: BMC præsenterer innovation, samarbejde og en fremtid med bedre vejrtrækning
CPAP Monitoring – What Needs to Change Today? opfordrede førende eksperter til et skift væk fra den traditionelle compliancemetrik på "4 timer/nat". Prof. Jean-Louis Pépin (Frankrig) understregede behovet
More news about: BMC Medical Co., Ltd.
Oct 01, 2025, 15:00 ET Composite Raises $5.6M to Liberate Professionals From Tedious Grunt Work
Backed by Nat Friedman, Daniel Gross, Menlo Ventures, and Anthropic, Composite transforms your browser into an intelligent autopilot that predicts and automates your busywork
More news about: Composite
Oct 01, 2025, 11:45 ET Gold Breaks $3,800 as Institutions Turn to Junior Miners
approved by Lake Victoria Gold Ltd. Technical information relating to Lake Victoria Gold Ltd. has been reviewed and approved by David Scott, Pr. Sci. Nat., a Qualified Person as defined by National Instrument 43-101. Mr. Scott is a registered member of the South African Council for Natural Scientific Professions
More news about: USA News Group
Oct 01, 2025, 11:15 ET Gold Surges Past $3,800 as Institutions Eye Junior Mining Opportunity
approved by Lake Victoria Gold Ltd. Technical information relating to Lake Victoria Gold Ltd. has been reviewed and approved by David Scott, Pr. Sci. Nat., a Qualified Person as defined by National Instrument 43-101. Mr. Scott is a registered member of the South African Council for Natural Scientific Professions
More news about: Equity Insider
Oct 01, 2025, 05:10 ET VERTANICAL Announces Positive Results From the VER-01 Phase 3 Program for the Treatment of Chronic Low Back Pain (CLBP)
Keßler J, Schoder V, Häuser W. Full-spectrum extract from Cannabis sativa DKJ127 for chronic back pain: a randomized, placebo-controlled phase 3 study. Nat Med (2025), published online on September 29, 2025, doi: 10.1038/s41591-025-03977-03 Wu A, March L, Zheng X, et al. Global low back
More news about: Vertanical
Oct 01, 2025, 04:48 ET VERTANICAL Announces Positive Results From the VER-01 Phase 3 Program for the Treatment of Chronic Low Back Pain (CLBP)
Keßler J, Schoder V, Häuser W. Full-spectrum extract from Cannabis sativa DKJ127 for chronic back pain: a randomized, placebo-controlled phase 3 study. Nat Med (2025), published online on September 29, 2025, doi: 10.1038/s41591-025-03977-03 Wu A, March L, Zheng X, et al. Global low back
More news about: Vertanical
Sep 30, 2025, 17:23 ET Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)
2022;149(6):1819-1831. doi:10.1016/j.jaci.2022.04.010 Kolkhir, P., Giménez-Arnau, A.M., Kulthanan, K. et al. Urticaria. Nat Rev Dis Primers. 8, 61 (2022). https://doi.org/10.1038/s41572-022-00389-z
More news about: Novartis Pharmaceuticals Corporation
Sep 30, 2025, 12:59 ET Wahlburgers Serves Up Stackhouse Smashburger and Wicked Sodas to Celebrate Release of "Play Dirty" - Streaming Globally on Prime Video October 1
Directed by Shane BlackStarring Mark Wahlberg, LaKeith Stanfield, Rosa Salazar, Keegan-Michael Key, Chukwudi Iwuji, Nat Wolff with Thomas Jane and Tony ShalhoubWritten by Shane Black & Charles Mondry & Anthony BagarozziBased on The
More news about: Wahlburgers